Polyurethane-based polymer tissue engineering blood vessel and preparation method thereof

Polyurethane-based micron fiber membranes were prepared through electrospinning technology, and tissue-engineering blood vessels of different sizes were stimulated by liquid environment, which solved the problems of inadequate size adaptation and insufficient binding capacity in the prior art, and achieved efficient and stable vascular construction, satisfying the Clinical needs.

CN118903546APending Publication Date: 2024-11-08EAST CHINA JIAOTONG UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410988310.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art is difficult to quickly construct tissue engineered blood vessels of different sizes, especially small diameter vessels, and lacks good binding capabilities, making it difficult to meet the clinical needs in emergencies.

Method used

Electrospinning technology is used to prepare polyurethane-based micron fiber membranes with different orientations. Through liquid environment stimulation, it is self-curled to form tubular blood vessels of the required size. Combined with medical polymer materials such as polylactic acid, polycaprolactone and polyethersulfone, it is formed. The two-layer structure interwoven between layers improves the sealing and biocompatibility of blood vessels.

Benefits of technology

It realizes the rapid construction of tissue engineered blood vessels of different sizes according to needs, has good binding ability, hemocompatibility and biocompatibility, meets the clinical needs in emergencies, and shows high stability when applied in humans. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903546A_ABST
    Figure CN118903546A_ABST
Patent Text Reader

Abstract

The invention discloses a polyurethane-based polymer tissue engineering blood vessel. The tissue engineering blood vessel is a tubular object with the inner diameter of 3-6 mm and the wall thickness of 0.10-0.72 mm, wherein polyurethane-based micron fiber membranes with different orientations are self-curled in an absolute ethyl alcohol or isopropyl alcohol liquid environment for 10 s to form the tubular object, and the inner diameter of the tubular object ranges from 3 mm to 6 mm, and the wall thickness of the tubular object ranges from 0.10 mm to 0.72 mm. The component of the micron fiber membrane with different orientations is polyurethane or a mixture of polyurethane and a medical polymer material, the micron fiber membrane is prepared by adopting an electrostatic spinning technology, and in the electrostatic spinning process, micron fibers with different orientations on the front and back surfaces are obtained by changing the rotating speed of a roller; the tissue engineering blood vessel is good in leakproofness, not only has good blood compatibility and biocompatibility, but also is high in bursting pressure and has good combining capacity. According to the method, the length-width ratios of the micron fiber membranes with different orientations can be selected according to requirements, so that the polyurethane-based high-molecular tissue engineering blood vessels with different inner diameters and wall thicknesses can be rapidly prepared, and clinical requirements under emergency conditions can be met.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a tissue engineering blood vessel, in particular to a polyurethane-based polymer tissue engineering blood vessel that can be quickly constructed. Background Art

[0002] Cardiovascular disease and vascular trauma have become one of the major diseases that endanger human health. According to the World Health Organization, 17.5 million people died of cardiovascular-related diseases in 2013. It is estimated that by 2030, the number of deaths caused by cardiovascular diseases will rise to 23.6 million per year. Tissue engineering vascular interventional medicine has become the main means of treating cardiovascular diseases due to its advantages of less trauma, quick effect and high success rate.

[0003] Tissue-engineered blood vessels refer to vascular tissue substitutes that imitate the composition and physiological functions of ideal blood vessels and have a certain degree of biocompatibility. The large-diameter blood vessels currently constructed have good clinical applications. However, small-diameter blood vessels, especially those with a diameter of less than 6 mm, are prone to vascular blockage. The key to solving this problem is rapid endothelialization. Endothelial cells on the surface of tissue-engineered blood vessels can reduce intimal hyperplasia and improve long-term patency. However, planting endothelial cells in artificial small blood vessels is not only difficult to operate and difficult to form a uniform cell layer; moreover, the size of blood vessels varies from patient to patient and from lesion to lesion. Therefore, a simple method for quickly constructing tissue-engineered blood vessels is needed to meet clinical needs in emergency situations.

[0004] In terms of tissue engineering blood vessels, there is currently a rapid preparation technology. The patent document with publication number CN115998959A and publication date April 25, 2023 discloses a thermally self-curling polymer tubular stent and its preparation method. The electrospinning technology is used to prepare a thermally self-curling polymer planar stent, which can achieve thermal response to obtain a tubular stent. It has good biocompatibility and degradation performance, but it does not have binding ability and will expand when a small pressure is applied.

[0005] The patent document with publication number CN115970050A and publication date April 18, 2023 discloses a double-layer film for tissue engineering small blood vessels or vascular stents and its preparation and application. The tissue engineering small blood vessels or vascular stents are obtained by 3D printing technology. The double-layer film is obtained under the stimulation of a liquid environment and has good blood compatibility and biocompatibility, but it still does not have binding ability. At present, there is no technology or material that can quickly construct tissue engineering blood vessels of different sizes and with good binding ability according to demand. Summary of the invention

[0006] In response to the above-mentioned prior art, the present invention provides a polyurethane-based polymer tissue engineering blood vessel that can be quickly constructed. The polyurethane-based polymer tissue engineering blood vessel is tubular and composed of micron fiber membranes with different orientations. It can produce self-curling behavior under the stimulation of liquid environment. Therefore, the micron fiber membranes with different orientations can be self-curled into tissue engineering blood vessels of required size under the stimulation of liquid environment according to needs.

[0007] In order to solve the above technical problems, the present invention proposes a polyurethane-based polymer tissue engineering blood vessel, which is a tubular object with an inner diameter of 3 to 6 mm and a wall thickness of 0.10 to 0.72 mm formed by self-curling polyurethane-based micron fiber membranes with different orientations in an anhydrous ethanol or isopropanol liquid environment for 10 seconds; the components of the micron fiber membranes with different orientations are polyurethane or a mixture of polyurethane and medical polymer materials, and are prepared by electrospinning technology; the tissue engineering blood vessel has good airtightness, good binding ability, good blood compatibility and biocompatibility; the bursting pressure is 531 to 1258 mmHg, the hemolysis rate of the outer layer is 0.095 to 0.13%, and the hemolysis rate of the inner layer is 0.039 to 0.054%.

[0008] Furthermore, the polyurethane-based polymer tissue engineering blood vessel of the present invention comprises:

[0009] The polyurethane-based micron fiber membranes with different orientations have a fiber diameter of 0.6 to 0.7 μm; the polyurethane-based micron fiber membranes with different orientations include two interlaced layers, one layer is an oriented micron fiber membrane, and the other layer is a non-oriented micron fiber membrane. The thickness of the oriented micron fiber membrane is 0.05 to 0.07 mm, and the total thickness of the two layers is 0.10 to 0.24 mm.

[0010] When the polyurethane-based micron fiber membrane component includes a medical polymer material, the medical polymer material is one of polylactic acid, polycaprolactone and polyethersulfone, and the weight ratio of the polyurethane to the medical polymer material is (1.5-9):1.

[0011] At the same time, the present invention also proposes a method for preparing the above-mentioned polyurethane-based polymer tissue engineering blood vessel, comprising the following steps:

[0012] Step 1) Preparation of micron fiber membranes with different orientations: polyurethane and medical polymer materials are weighed and mixed evenly according to a weight ratio of (1.5-9): 0-1, and the mixture is dissolved in an organic solvent according to a weight volume ratio of (1.2-3.2) g / 10 mL, and a polymer homogeneous solution is obtained after stirring for 6 hours; electrospinning technology is used to prepare micron fiber membranes with different orientations and a fiber diameter of 0.6-0.7 μm, and the process parameters of electrospinning include: a spinning solution flow rate of 0.008-0.016 mL / min, a spinning voltage of 8-15 kV, and a receiving distance of 12-18 cm; the process of electrospinning is: first, the drum speed is set to 1800-2200 rpm for 4 hours to obtain an oriented micron fiber membrane with a thickness of 0.05-0.07 mm, and then the drum speed is set to 100-500 rpm for 4 hours to obtain a micron fiber membrane with a total thickness of 0.10-0.24 mm;

[0013] Step 2) Preparation of polyurethane-based polymer tissue engineering blood vessels: Measure the differently oriented micron fiber membranes prepared in step 1) according to a length-to-width ratio of 1:(0.75-6) and place them in anhydrous ethanol or isopropanol liquid environment. After 10 seconds, a tubular object with an inner diameter of 3-6 mm and a wall thickness of 0.10-0.72 mm is obtained.

[0014] Furthermore, the preparation method of the present invention, wherein:

[0015] In step 1), the medical polymer material is one of polylactic acid, polycaprolactone and polyethersulfone.

[0016] In step 1), the organic solvent is one of dimethylformamide, dimethylacetamide, dichloromethane, dichloroethylene and trichloroethylene.

[0017] Compared with the prior art, the present invention has the following beneficial effects:

[0018] (1) The present invention can quickly obtain tissue engineering blood vessels of required size according to demand to meet clinical needs in emergency situations.

[0019] (2) The polyurethane-based polymer tissue-engineered blood vessels can respond to the liquid environment, which greatly facilitates their application in the human body.

[0020] (3) The polyurethane-based polymer tissue engineering blood vessels have high burst pressure, good biocompatibility and blood compatibility. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 It is the macroscopic morphology of polyurethane-based polymer tissue-engineered blood vessels of different sizes.

[0022] Figure 2This is the macroscopic morphology of tissue-engineered blood vessels prepared from micron-fiber membranes with different aspect ratios.

[0023] Figure 3 This is a photo of testing the airtightness of polyurethane-based polymer tissue-engineered blood vessels.

[0024] Figure 4 It is the microscopic morphology of polyurethane-based polymer tissue engineering blood vessels.

[0025] Figure 5 The bursting pressure of micron fiber membranes with different aspect ratios self-curled into tissue engineering blood vessels.

[0026] Figure 6 It is the hemolysis rate of the front and back sides of the micron fiber membrane with different orientations before and after liquid treatment.

[0027] Figure 7 These are live staining photos of endothelial cells cultured on the surfaces of the inner and outer layers of microfiber membranes with different orientations before and after liquid treatment for 1, 3, and 5 days.

[0028] Figure 8 The proliferation of endothelial cells cultured on the surfaces of the inner and outer layers of microfiber membranes with different orientations before and after liquid treatment for 1, 3 and 5 days respectively. DETAILED DESCRIPTION

[0029] The invention realizes the design idea of ​​rapidly preparing polyurethane-based polymer tissue engineering blood vessels: after obtaining micron fiber membranes with different orientations by electrospinning technology, they are stimulated to rapidly self-curl in anhydrous ethanol or isopropanol liquid environment. Wherein, the micron fiber membranes with different orientations are obtained by changing the rotation speed of the roller in the electrospinning process by means of polyurethane or spinning solution prepared with polyurethane and medical polymer materials as raw materials, and the specific steps are: after weighing polyurethane and medical polymer materials in a weight ratio of (1.5-9): (0-1) and mixing them evenly, dissolving the mixture in an organic solvent in a weight volume ratio of (1.2-3.2) g / 10 mL, and stirring for 6 hours to obtain a polymer homogeneous solution; and preparing two layers of micron fiber membranes with different orientations and interlayer interweaving with a fiber diameter of 0.6-0.7 μm by means of electrospinning technology, wherein one layer is an oriented micron fiber membrane and the other layer is a non-oriented micron fiber membrane, the thickness of the oriented micron fiber membrane is 0.05-0.07 mm, and the total thickness of the two layers is 0.10-0.24 mm. The process parameters of electrospinning include: a spinning solution flow rate of 0.008-0.016 mL / min, a spinning voltage of 8-15 kV, and a receiving distance of 12-18 cm; the process of electrospinning is: first, the drum speed is set to 1800-2200 rpm for 4 hours to obtain an oriented micron fiber membrane with a thickness of 0.05-0.07 mm, and then the drum speed is set to 100-500 rpm for 4 hours to obtain different oriented micron fiber membranes with a total thickness of 0.10-0.24 mm; the above-mentioned fiber membranes with different aspect ratios can be quickly self-curled to form a tubular object with an inner diameter of 3-6 mm and a wall thickness of 0.10-0.72 mm in an anhydrous ethanol or isopropanol liquid environment after 10 seconds; the tubular object is the polyurethane-based polymer tissue engineering blood vessel. The present invention can select the aspect ratio of micron fiber membranes with different orientations according to the needs, and the selection range is 1: (0.75-6), so as to quickly prepare polyurethane-based polymer tissue engineering blood vessels with different inner diameters and wall thicknesses to meet clinical needs in emergency situations. The tissue engineering blood vessels have good airtightness, not only good blood compatibility and biocompatibility, but also high burst pressure and good binding ability. Its burst pressure is 531-1258 mmHg, the hemolysis rate of the outer layer is 0.095-0.13%, and the hemolysis rate of the inner layer is 0.039-0.054%.

[0030] When the components of the polyurethane-based micron fiber membrane include a medical polymer material, the medical polymer material is one of polylactic acid, polycaprolactone and polyethersulfone.

[0031] The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments, but the following embodiments are by no means intended to limit the present invention in any way.

[0032] Example 1

[0033] Rapid preparation of polyurethane-based polyethersulfone tissue-engineered blood vessels with an inner diameter of 4 mm and a wall thickness of 0.12 mm, the steps are as follows:

[0034] Step 1) Preparation of micron fiber membranes with different orientations: weigh 2.7 g of polyurethane and 0.3 g of polyethersulfone, mix them evenly, dissolve them in 10 mL of dimethylacetamide, and stir for 6 hours to obtain a polymer homogeneous solution; use the polymer homogeneous solution as the spinning solution, and adopt electrospinning technology to prepare micron fiber membranes with different orientations. The electrospinning process is as follows: the spinning solution flow rate is 0.01 mL / min, the spinning voltage is 12 kV, and the receiving distance is 16 cm; first, the drum speed is set to 2000 rpm, and after 4 hours, an oriented micron fiber membrane with a thickness of 0.06 mm is obtained, and then the drum speed is changed to 100 rpm. After 4 hours, a non-oriented micron fiber membrane interlaced with the oriented micron fiber membrane layer is obtained, thereby obtaining a micron fiber membrane with different orientations with a total thickness of 0.12 mm.

[0035] Step 2) Preparation of polyurethane-based polyethersulfone tissue engineering blood vessels: Take a sample of the differently oriented micron fiber membranes prepared in step 1) with a length × width of 4 cm × 3 cm and immerse it in anhydrous ethanol liquid environment. After 10 seconds, a polyurethane-based polyethersulfone tissue engineering blood vessel with an inner diameter of 4 mm and a wall thickness of 0.12 mm is obtained.

[0036] Example 2

[0037] Rapidly prepare polyurethane-based polyethersulfone tissue engineering blood vessels with an inner diameter of 4 mm and a wall thickness of 0.24 mm.

[0038] This embodiment is basically the same as embodiment 1, except that in step 2), the length × width of the measured sample is changed from 4 cm × 3 cm to 4 cm × 5 cm, and finally a polyurethane-based polyethersulfone tissue engineering blood vessel with an inner diameter of 4 mm and a wall thickness of 0.24 mm is obtained.

[0039] Example 3

[0040] Rapid preparation of polyurethane-based polyethersulfone tissue engineering blood vessels with an inner diameter of 4 mm and a wall thickness of 0.36 mm.

[0041] This embodiment is basically the same as embodiment 1, except that in step 2), the length × width of the measured sample is changed from 4 cm × 3 cm to 4 cm × 6 cm, and finally a polyurethane-based polymer tissue engineering blood vessel with an inner diameter of 4 mm and a wall thickness of 0.36 mm is obtained.

[0042] Example 4

[0043] Rapidly prepare polyurethane-based polyethersulfone tissue engineering blood vessels with an inner diameter of 6 mm and a wall thickness of 0.24 mm. The steps are as follows:

[0044] Step 1) Preparation of micron fiber membranes with different orientations: weigh 1.92 g of polyurethane and 1.28 g of polyethersulfone, mix them evenly, dissolve them in 10 mL of dimethylacetamide, and stir for 6 hours to obtain a polymer homogeneous solution; use the polymer homogeneous solution as the spinning solution, and adopt electrospinning technology to prepare micron fiber membranes with different orientations: the electrospinning process is as follows: the spinning solution flow rate is 0.016 mL / min, the spinning voltage is 15 kV, and the receiving distance is 18 cm; first, the drum speed is set to 2200 rpm, and after 4 hours, an oriented micron fiber membrane with a thickness of 0.05 mm is obtained, and then the drum speed is changed to 500 rpm. After 4 hours, a non-oriented micron fiber membrane interlaced with the oriented micron fiber membrane layer is obtained, thereby obtaining a micron fiber membrane with different orientations with a total thickness of 0.10 mm.

[0045] Step 2) Preparation of polyurethane-based polyethersulfone tissue engineering blood vessels: Take a sample of the differently oriented micron fiber membranes prepared in step 1) with a length × width of 1 cm × 3 cm and immerse it in anhydrous ethanol liquid environment. After 10 seconds, a polyurethane-based polyethersulfone tissue engineering blood vessel with an inner diameter of 6 mm and a wall thickness of 0.24 mm is obtained.

[0046] Example 5

[0047] Rapid preparation of polyurethane-based polyethersulfone tissue engineering blood vessels with an inner diameter of 6 mm and a wall thickness of 0.48 mm.

[0048] This embodiment is basically the same as embodiment 4, except that in step 2), the length × width of the measured sample is changed from 1 cm × 3 cm to 1 cm × 5 cm, and finally a polyurethane-based polyethersulfone tissue engineering blood vessel with an inner diameter of 6 mm and a wall thickness of 0.48 mm is obtained.

[0049] Example 6

[0050] Rapidly prepare polyurethane-based polyethersulfone tissue engineering blood vessels with an inner diameter of 6 mm and a wall thickness of 0.72 mm.

[0051] This embodiment is basically the same as embodiment 4, except that in step 2), the length × width of the measured sample is changed from 1 cm × 3 cm to 1 cm × 6 cm, and finally a polyurethane-based polyethersulfone tissue engineering blood vessel with an inner diameter of 6 mm and a wall thickness of 0.48 mm is obtained.

[0052] Example 7

[0053] Rapidly prepare polyurethane-based polyethersulfone tissue engineering blood vessels with an inner diameter of 3 mm and a wall thickness of 0.12 mm. The steps are as follows:

[0054] Step 1) Preparation of micron fiber membranes with different orientations: weigh 0.96 g of polyurethane and 0.24 g of polyethersulfone, mix them evenly, dissolve them in 10 mL of dimethylformamide, and stir for 6 hours to obtain a polymer homogeneous solution; use the polymer homogeneous solution as the spinning solution, and adopt electrospinning technology to prepare micron fiber membranes with different orientations: the electrospinning process is as follows: the spinning solution flow rate is 0.008 mL / min, the spinning voltage is 8 kV, and the receiving distance is 12 cm; first, the drum speed is set to 1800 rpm, and after 4 hours, an oriented micron fiber membrane with a thickness of 0.06 mm is obtained, and then the drum speed is changed to 300 rpm. After 4 hours, a non-oriented micron fiber membrane interlaced with the oriented micron fiber membrane layer is obtained, thereby obtaining a micron fiber membrane with different orientations with a total thickness of 0.12 mm.

[0055] Step 2) Preparation of polyurethane-based polyethersulfone tissue engineering blood vessels: Take a sample of the differently oriented micron fiber membranes prepared in step 1) with a length × width of 2 cm × 3 cm and immerse it in anhydrous ethanol liquid environment. After 10 seconds, a polyurethane-based polyethersulfone tissue engineering blood vessel with an inner diameter of 3 mm and a wall thickness of 0.12 mm is obtained.

[0056] Example 8

[0057] Rapid preparation of polyurethane-based polyethersulfone tissue engineering blood vessels with an inner diameter of 3 mm and a wall thickness of 0.24 mm.

[0058] This embodiment is basically the same as embodiment 7, except that in step 2), the length × width of the measured sample is changed from 2 cm × 3 cm to 2 cm × 5 cm, and finally a polyurethane-based polyethersulfone tissue engineering blood vessel with an inner diameter of 3 mm and a wall thickness of 0.24 mm is obtained.

[0059] Example 9

[0060] Rapid preparation of polyurethane-based polyethersulfone tissue engineering blood vessels with an inner diameter of 3 mm and a wall thickness of 0.36 mm.

[0061] This embodiment is basically the same as embodiment 7, except that in step 2), the length × width of the measured sample is changed from 2 cm × 3 cm to 2 cm × 6 cm, and finally a polyurethane-based polyethersulfone tissue engineering blood vessel with an inner diameter of 3 mm and a wall thickness of 0.36 mm is obtained.

[0062] Example 10

[0063] Rapidly prepare polyurethane tissue-engineered blood vessels with an inner diameter of 3 mm and a wall thickness of 0.12 mm. The steps are as follows:

[0064] Step 1) Preparation of micron fiber membranes with different orientations: 1.8 g of polyurethane was dissolved in 10 mL of dimethylacetamide and stirred for 6 hours to obtain a polymer homogeneous solution; the polymer homogeneous solution was used as the spinning solution and electrospinning technology was used to prepare micron fiber membranes with different orientations: the electrospinning process was as follows: the spinning solution flow rate was 0.01 mL / min, the spinning voltage was 12 kV, and the receiving distance was 16 cm; first, the drum speed was set to 2000 rpm, and after 4 hours, an oriented micron fiber membrane with a thickness of 0.06 mm was obtained, and then the drum speed was changed to 200 rpm. After 4 hours, a non-oriented micron fiber membrane interlaced with the oriented micron fiber membrane layer was obtained, thereby obtaining micron fiber membranes with different orientations with a total thickness of 0.12 mm.

[0065] Step 2) Preparation of polyurethane tissue-engineered blood vessels: Take a sample with a length × width of 2 cm × 3 cm from the differently oriented micron fiber membranes with a thickness of 0.12 mm prepared in step 1) with the fiber direction of the oriented micron fiber membrane as the width and immerse it in anhydrous ethanol liquid environment. After 10 seconds, a polyurethane tissue-engineered blood vessel with an inner diameter of 3 mm and a wall thickness of 0.12 mm is obtained.

[0066] Embodiment 11

[0067] Rapidly prepare polyurethane tissue engineering blood vessels with an inner diameter of 3mm and a wall thickness of 0.24mm.

[0068] This embodiment is basically the same as embodiment 10, except that in step 2), the length × width of the measured sample is changed from 2 cm × 3 cm to 2 cm × 5 cm, and finally a polyurethane tissue engineering blood vessel with an inner diameter of 3 mm and a wall thickness of 0.24 mm is obtained.

[0069] Example 12

[0070] Rapidly prepare polyurethane tissue engineering blood vessels with an inner diameter of 3mm and a wall thickness of 0.24mm.

[0071] This embodiment is basically the same as embodiment 10, except that in step 2), the length × width of the measured sample is changed from 2 cm × 3 cm to 2 cm × 6 cm, and finally a polyurethane tissue engineering blood vessel with an inner diameter of 3 mm and a wall thickness of 0.36 mm is obtained.

[0072] Example 13

[0073] Rapidly prepare polyurethane-based polycaprolactone tissue engineering blood vessels with an inner diameter of 3 mm and a wall thickness of 0.10 mm. The steps are as follows:

[0074] Step 1) Preparation of micron fiber membranes with different orientations: Weigh 2.4g of polyurethane and 0.6g of polycaprolactone, mix them evenly, dissolve them in 10mL of dimethylacetamide, and stir for 6h to obtain a polymer homogeneous solution; use the polymer homogeneous solution as the spinning solution, and adopt electrospinning technology to prepare micron fiber membranes with different orientations: the electrospinning process is as follows: the spinning solution flow rate is 0.008mL / min, the spinning voltage is 10kV, and the receiving distance is 14cm; first, the drum speed is set to 1900rpm, and after 4h, an oriented micron fiber membrane with a thickness of 0.05mm is obtained, and then the drum speed is changed to 300rpm. After 4h, a non-oriented micron fiber membrane interlaced with the oriented micron fiber membrane layer is obtained, thereby obtaining micron fiber membranes with different orientations with a total thickness of 0.10mm.

[0075] Step 2) Preparation of polyurethane-based polycaprolactone tissue engineering blood vessels: Take a sample with a length × width of 2 cm × 3 cm from the differently oriented micron fiber membranes with a thickness of 0.10 mm prepared in step 1) with the fiber direction of the oriented micron fiber membrane as the width and immerse it in anhydrous ethanol liquid environment. After 10 seconds, a polyurethane-based polycaprolactone tissue engineering blood vessel with an inner diameter of 3 mm and a wall thickness of 0.10 mm is obtained.

[0076] Embodiment 14

[0077] Rapidly prepare polyurethane-based polycaprolactone tissue engineering blood vessels with an inner diameter of 3 mm and a wall thickness of 0.20 mm.

[0078] This embodiment is basically the same as embodiment 13, with the only difference being that in step 2), the length × width of the measured sample is changed from 2 cm × 3 cm to 2 cm × 5 cm, and finally a polyurethane-based polycaprolactone tissue engineering blood vessel with an inner diameter of 3 mm and a wall thickness of 0.20 mm is obtained.

[0079] Embodiment 15

[0080] Rapidly prepare polyurethane-based polycaprolactone tissue engineering blood vessels with an inner diameter of 3 mm and a wall thickness of 0.30 mm.

[0081] This embodiment is basically the same as embodiment 13, with the only difference being that in step 2), the length × width of the measured sample is changed from 2 cm × 3 cm to 2 cm × 6 cm, and finally a polyurethane-based polycaprolactone tissue engineering blood vessel with an inner diameter of 3 mm and a wall thickness of 0.30 mm is obtained.

[0082] Research Materials

[0083] In the present invention, "self-curling" refers to the behavior of a planar microfiber membrane curling spontaneously into a tubular structure in a liquid environment.

[0084] Figure 1 , 24 and 5 are macroscopic and microscopic photos of a polyurethane-based polymer tissue engineering blood vessel that can be quickly constructed prepared by the present invention. Figure 1 As shown, a is the macroscopic morphology of polyurethane-based polymer tissue engineering blood vessels with the same inner diameter but different lengths, and b is the macroscopic morphology of polyurethane-based polymer tissue engineering blood vessels with the same length but different inner diameters. Polyurethane-based polymer tissue engineering blood vessels of different sizes can be prepared according to needs. Tissue engineering blood vessels need to have good airtightness, so the airtightness of polyurethane-based polymer tissue engineering blood vessels is tested. Specifically, Figure 3 As shown, two syringes are prepared, wherein the barrel of the first syringe is filled with red ink, and there is a certain space between the piston in the barrel of the second syringe and the liquid outlet. The two ends of the tissue engineering blood vessel prepared in Example 1 are sealed and connected to the needle seats of the first and second syringes through fixing bands, and the plunger push rod of the second syringe is slowly pushed until red ink seeps out of the surface of the tissue engineering blood vessel. The pressure is about 0.5MPa, which proves that the tissue engineering blood vessel prepared by the present invention has good airtightness. Under the stimulation of the liquid environment, the micron fiber membranes with different orientations prepared by electrospinning technology are self-curled from the flat fiber membranes into tissue engineering blood vessels. Taking Examples 1, 2, and 3 as examples, Figure 2 From left to right in a and b, it is shown that the planar microfiber membranes of Examples 1, 2, and 3 with aspect ratios of 4:3, 4:5, and 4:6, respectively, are self-curled into tissue engineering blood vessels with different numbers of layers after being stimulated by a liquid environment. Figure 4 This is the micromorphology of the polyurethane-based polyethersulfone tissue engineering blood vessel prepared in Example 1, wherein a is the micromorphology of the outer layer before liquid stimulation, b is the micromorphology of the inner layer before liquid stimulation, c is the micromorphology of the outer layer after liquid stimulation, and d is the micromorphology of the inner layer after liquid stimulation. It can be seen that the straight fibers become wavy fibers after stimulation in an anhydrous ethanol liquid environment.

[0085] The bursting pressure refers to the pressure that a blood vessel withstands when it is subjected to gradually increasing pressure until it ruptures. The higher the bursting pressure of an artificial blood vessel, the better its pressure resistance and the higher its reliability after being implanted in the human body. The tissue engineering blood vessels prepared in Examples 1, 2 and 3 were subjected to a bursting pressure test. Specifically, in the present invention, the bursting pressure test is to connect one end of the tissue engineering blood vessel to a pressure gauge and the other end to a syringe filled with water, and slowly push the plunger of the syringe. When the tissue engineering blood vessel ruptures, the pressure on the pressure gauge is recorded, which is the bursting pressure of the tissue engineering blood vessel. Tables 1 and Figure 5The bursting pressures of Examples 1 to 9 are shown as test results. It can be seen that the bursting pressure of the tissue engineering blood vessel increases with the decrease of the aspect ratio of the micron fiber membrane. The bursting pressures of Examples 1 to 3 are 721.80±19.89, 957.39±35.53, and 1160.40±37.84 mmHg, respectively, and are all much greater than the normal blood pressure of the human body (80-120 mmHg), indicating that the tissue engineering blood vessel has good pressure resistance, which can also be explained from the side that it has good airtightness.

[0086] Table 1

[0087] sample Burst pressure(mmHg) Example 1 721.80±19.89 Example 2 957.39±35.53 Example 3 1160.40±37.84 Example 4 531.33±15.65 Example 5 797.00±27.11 Example 6 1020±22.97 Example 7 839.6±22.97 Example 8 1105.26±30.08 Example 9 1258.15±11.49

[0088] For tissue engineering blood vessels implanted in the human body, it is necessary to evaluate their blood compatibility. Generally, a hemolysis rate of less than 5% means that the damage to red blood cells is small and the blood compatibility is good. The hemolysis rate of the tissue engineering blood vessels prepared in Examples 1 to 9 was tested, and the blood used was fresh anticoagulated rabbit blood. From Table 2 and Figure 6 It can be seen that the hemolysis rates of the outer layer of the micron fiber membrane after liquid environment stimulation were 0.130±0.003%, 0.095±0.003%, and 0.106±0.006%, respectively, and the hemolysis rates of the inner layer were 0.054±0.006%, 0.039±0.006%, and 0.048±0.005%, respectively, indicating that the tissue engineered blood vessels have good blood compatibility.

[0089] Table 2

[0090] sample Outer layer hemolysis rate (%) Inner layer hemolysis rate (%) Example 1 0.130±0.003 0.054±0.006 Example 2 0.130±0.003 0.054±0.006 Example 3 0.130±0.003 0.054±0.006 Example 4 0.095±0.003 0.039±0.006 Example 5 0.095±0.003 0.039±0.006 Example 6 0.095±0.003 0.039±0.006 Example 7 0.106±0.006 0.048±0.005 Example 8 0.106±0.006 0.048±0.005 Example 9 0.106±0.006 0.048±0.005

[0091] Endothelial cells are the most important cell type in vascular tissue, so endothelial cells were selected to analyze the biocompatibility of the microfiber membrane. Figure 7 The live staining photos of endothelial cells cultured on the inner and outer surfaces of microfiber membranes for 1, 3 and 5 days before and after liquid environment stimulation are shown. Scale bar: 100 μm. Figure 7 It can be seen that the endothelial cells proliferated rapidly on the inner and outer surfaces of the microfiber membrane before and after the liquid environment stimulation. Some cells spread on the third day, and most of the cells spread on the fifth day, which shows that the microfiber membrane has good biocompatibility. Figure 8 The results of CCK-8 cell proliferation of endothelial cells cultured on the inner and outer surfaces of microfiber membranes for 1, 3, and 5 days before and after liquid environment stimulation are shown. Figure 8In the figure, the CCK-8 values ​​of the inner and outer surfaces at 1, 3 and 5 days before and after liquid stimulation were 0.41±0.01, 0.19±0.01, 0.48±0.01, 0.23±0.01, 1.37±0.01, 1.07±0.01, 1.49±0.01, 1.26±0.01, 2.39±0.02, 2.05±0.04, 2.42±0.01 and 2.16±0.02, respectively. It can be seen that with the increase of culture time, the cell activity gradually increased, and the proliferation effect was maintained continuously within 5 days, indicating that endothelial cells can achieve rapid proliferation on both sides of the microfiber membrane before and after liquid environment stimulation, further indicating that the microfiber membrane has good biocompatibility.

[0092] Although the present invention has been described above in conjunction with the accompanying drawings, the present invention is not limited to the above-mentioned specific embodiments, which are merely illustrative rather than restrictive. Under the guidance of the present invention, ordinary technicians in this field can make many improvements and changes without departing from the purpose of the present invention, which are all within the protection of the present invention.

Claims

1. A polyurethane-based polymer tissue engineering blood vessel, It is characterized in that The tissue engineering blood vessel is formed by self-curling polyurethane-based micron fiber membranes with different orientations in an anhydrous ethanol or isopropanol liquid environment for 10 seconds to form a tubular object with an inner diameter of 3 to 6 mm and a wall thickness of 0.10 to 0.72 mm; the components of the micron fiber membranes with different orientations are polyurethane or a mixture of polyurethane and medical polymer materials, and are prepared by electrostatic spinning technology; the tissue engineering blood vessel has good airtightness, good binding ability, good blood compatibility and biocompatibility; the bursting pressure is 531 to 1258 mmHg, the hemolysis rate of the outer layer is 0.095 to 0.13%, and the hemolysis rate of the inner layer is 0.039 to 0.054%.

2. The polyurethane-based polymer tissue engineering blood vessel according to claim 1, It is characterized in that The polyurethane-based micron fiber membranes with different orientations have a fiber diameter of 0.6 to 0.7 μm; the polyurethane-based micron fiber membranes with different orientations include two interlaced layers, one layer is an oriented micron fiber membrane, and the other layer is a non-oriented micron fiber membrane. The thickness of the oriented micron fiber membrane is 0.05 to 0.07 mm, and the total thickness of the two layers is 0.10 to 0.24 mm.

3. The polyurethane-based polymer tissue engineering blood vessel according to claim 1, It is characterized in that When the components of the polyurethane-based micron fiber membrane include medical polymer materials, the medical polymer materials are one of polylactic acid, polycaprolactone and polyethersulfone, and the weight ratio of the polyurethane to the medical polymer materials is (1.5-9):

1.

4. A method for preparing a polyurethane-based polymer tissue engineering blood vessel, It is characterized in that The following steps are involved: Step 1) Preparation of micron fiber membranes with different orientations: polyurethane and medical polymer materials are weighed and mixed evenly according to a weight ratio of (1.5-9): 0-1, and the mixture is dissolved in an organic solvent according to a weight volume ratio of (1.2-3.2) g / 10 mL, and a polymer homogeneous solution is obtained after stirring for 6 hours; electrospinning technology is used to prepare micron fiber membranes with different orientations and a fiber diameter of 0.6-0.7 μm, and the process parameters of electrospinning include: a spinning solution flow rate of 0.008-0.016 mL / min, a spinning voltage of 8-15 kV, and a receiving distance of 12-18 cm; the process of electrospinning is: first, the drum speed is set to 1800-2200 rpm for 4 hours to obtain an oriented micron fiber membrane with a thickness of 0.05-0.07 mm, and then the drum speed is set to 100-500 rpm for 4 hours to obtain a micron fiber membrane with a total thickness of 0.10-0.24 mm; Step 2) Preparation of polyurethane-based polymer tissue engineering blood vessels: Measure the differently oriented micron fiber membranes prepared in step 1) according to a length-to-width ratio of 1:(0.75-6) and place them in anhydrous ethanol or isopropanol liquid environment. After 10 seconds, a tubular object with an inner diameter of 3-6 mm and a wall thickness of 0.10-0.72 mm is obtained.

5. The preparation method according to claim 4, It is characterized in that The medical polymer material is one of polylactic acid, polycaprolactone and polyethersulfone.

6. The preparation method according to claim 4, It is characterized in that The organic solvent in step 1) is one of dimethylformamide, dimethylacetamide, dichloromethane, dichloroethylene and trichloroethylene.